Test of Cure After H. pylori Eradication: Mandatory Standard of Care
Yes, you must recheck H. pylori status after completing eradication therapy—confirmation of eradication is now considered the standard of care for all patients. 1
Why Test of Cure is Essential
Persistent H. pylori infection is a negative prognostic marker for ulcer recurrence, bleeding complications, and treatment failure in MALT lymphoma. 1, 2 The success of eradication directly determines whether ulcers will remain healed long-term, making confirmation testing critical rather than optional. 1
Additionally, confirming eradication provides an indirect measure of antibiotic resistance patterns in your patient population, which helps guide future treatment decisions. 1
Timing: When to Perform the Test
Wait at least 4 weeks after completing treatment before testing. 1, 3 Testing earlier than 4 weeks will yield false-negative results because the gastric mucosa needs time to recover from treatment effects, and you may detect temporary bacterial suppression rather than true eradication. 1, 3
Special timing considerations:
- Bleeding peptic ulcers: Delay testing to 4-8 weeks after the bleeding episode 1, 3
- Gastric MALT lymphoma: Wait at least 6 weeks after eradication therapy 3
Which Test to Use
Use either the urea breath test (UBT) or a validated monoclonal stool antigen test—both are equally accurate and interchangeable. 1
Test performance characteristics:
- Urea breath test: Sensitivity 94.7-97%, specificity 95-100% 1, 3
- Monoclonal stool antigen test: Sensitivity and specificity >90% 1, 3
- Serology has NO role: Antibody levels remain elevated after eradication, making serology useless for confirming cure 1
The stool antigen test is particularly useful when patients must continue PPI therapy, as it may be less affected by acid suppression than the UBT. 3
Critical Pre-Test Preparation Requirements
Failure to properly prepare patients before testing is a common pitfall that leads to false-negative results. 1
Mandatory washout periods:
- Stop antibiotics and bismuth: At least 4 weeks before testing 1, 3
- Stop PPIs: At least 2 weeks (preferably 7-14 days) before testing 3
- Fasting: At least 6 hours before the test 1, 3
The stool antigen test may allow continued PPI use with less interference, but stopping PPIs remains preferable when possible. 3
High-Risk Scenarios Requiring Endoscopic Follow-Up
While non-invasive testing suffices for most patients, certain clinical scenarios mandate endoscopy with biopsy-based testing: 1
- Gastric ulcer patients: Require endoscopic follow-up to ensure complete ulcer healing AND confirm H. pylori eradication 1, 3
- Gastric MALT lymphoma: Must undergo upper endoscopy with biopsy, as persistent infection predicts treatment failure 1, 3
- Complicated peptic ulcer disease: Should have endoscopic confirmation when clinically indicated 1
What to Do After Testing
If eradication is confirmed:
- Discontinue PPI therapy in uncomplicated duodenal ulcer cases 1
- Continue PPI in gastric ulcer patients until complete healing is documented 1
- Continue PPI in complicated duodenal ulcer or bleeding ulcer patients until eradication is confirmed 1
- No further H. pylori testing is needed unless symptoms recur 1
If H. pylori persists:
- Never repeat the same antibiotic regimen—this leads to further resistance and treatment failure 1
- Use a completely different antibiotic combination, avoiding any antibiotics used in the first regimen 1
- After two treatment failures, pursue antibiotic susceptibility testing to guide third-line therapy 1
- Review prior antibiotic exposures: Avoid clarithromycin if the patient has received any macrolide, and avoid levofloxacin if they have received any fluoroquinolone 1
Common Pitfalls to Avoid
- Testing too early (before 4 weeks): Yields unreliable false-negative results 1
- Using serology for test of cure: Cannot distinguish active infection from past exposure 1
- Inadequate medication washout: PPIs, antibiotics, or bismuth taken too close to testing will cause false negatives 1, 3
- Assuming symptom resolution equals eradication: Only 38% of successfully treated patients report complete symptom resolution, meaning symptoms are an unreliable marker of cure 4
- Repeating the same failed regimen: This guarantees treatment failure due to antibiotic resistance 1